Page last updated: 2024-08-21

tetramethylpyrazine and Colonic Neoplasms

tetramethylpyrazine has been researched along with Colonic Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Ahn, KS; Blough, BE; Eng, H; Jung, YY; Kumar, AP; Mohan, CD; Namjoshi, OA; Narula, AS; Rangappa, KS; Sethi, G	1

Other Studies

1 other study(ies) available for tetramethylpyrazine and Colonic Neoplasms

Article	Year
2,3,5,6-Tetramethylpyrazine Targets Epithelial-Mesenchymal Transition by Abrogating Manganese Superoxide Dismutase Expression and TGFβ-Driven Signaling Cascades in Colon Cancer Cells. Biomolecules, 2022, 06-25, Volume: 12, Issue:7 Topics: Cell Line, Tumor; Cell Movement; Colonic Neoplasms; Epithelial-Mesenchymal Transition; Glycogen Synthase Kinase 3; Humans; Phosphatidylinositol 3-Kinases; Pyrazines; Superoxide Dismutase; Transforming Growth Factor beta	2022

Article

Year

2,3,5,6-Tetramethylpyrazine Targets Epithelial-Mesenchymal Transition by Abrogating Manganese Superoxide Dismutase Expression and TGFβ-Driven Signaling Cascades in Colon Cancer Cells.

Biomolecules, 2022, 06-25, Volume: 12, Issue:7

Topics: Cell Line, Tumor; Cell Movement; Colonic Neoplasms; Epithelial-Mesenchymal Transition; Glycogen Synthase Kinase 3; Humans; Phosphatidylinositol 3-Kinases; Pyrazines; Superoxide Dismutase; Transforming Growth Factor beta

2022